银屑病生物制剂长期维持治疗的专家指导意见OA
Expert recommendations for long-term maintenance therapy with biologic agents in psoriasis
本专家指导意见基于应用生物制剂长期维持治疗银屑病过程中遇到的问题,结合现有循证医学证据及临床实践经验,由广东省质控中心银屑病质控组专家对银屑病生物制剂长期维持治疗的目标、原则与策略进行了系统阐述.强调以长期稳定控制疾病为核心目标,在诱导治疗达到预期疗效后,通过复发风险评估与个体化决策,在维持原有效方案、治疗优化、阶梯式减量停药及转换等策略之间进行动态管理.同时提出长期随访与规范监测的重要性,并将体质量、饮食、戒烟限酒与运动纳入长期结局优化.目的是实现疗效、安全性与患者长期管理需求之间的平衡,为临床实践提供系统化的决策参考.
This expert recommendation addresses key challenges encountered in the long-term maintenance treatment of psoriasis with biologic agents.Based on current evidence from evidence-based medicine and accumulated clinical experience,experts from the Psoriasis Quality Control Group of Guangdong Provincial Quality Control Center systematically outline the therapeutic goals,principles,and strategies for long-term biologic maintenance therapy in psoriasis.The recommen-dations emphasize sustained and stable disease control as the primary objective.After achieving the expected therapeutic response during the induction phase,treatment strategies should be dy-namically individualized according to relapse risk assessment.Potential approaches include main-taining the initially effective regimen,optimizing treatment,stepwise dose reduction or discontinu-ation,and switching therapy when necessary.The recommendations also highlight the importance of long-term follow-up and standardized monitoring.Additionally,lifestyle factors,including body weight management,dietary optimization,smoking cessation,alcohol restriction,and regular physical activity,are incorporated into long-term outcome optimization.Overall,these recommen-dations aim to balance efficacy,safety,and long-term patient management needs,providing a structured decision-making framework for clinical practice.
广东省质控中心银屑病质控组;刘晓明
银屑病生物制剂长期维持治疗复发风险个体化治疗
psoriasisbiologic agentslong-term maintenance therapyrelapse riskindividualized treatment
《皮肤性病诊疗学杂志》 2026 (3)
161-169,9
评论